Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CTRI | AUPH |
|---|---|---|
| Price | $20.72 | $15.72 |
| Change today | ▼ 0.91% | ▼ 0.69% |
| Market cap | $2.09B | $2.09B |
| Return, 3 months | -22.0% | -3.1% |
| Return, year to date | -17.9% | -1.4% |
| Return, 1 year | +3.6% | +38.9% |
| P/E (TTM) | 62.8 | 6.9 |
| P/B | 2.4 | 3.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +20.4% |
| Net profit growth (YoY) | – | +4,893.1% |
| Gross margin | – | 88.5% |
| Operating margin | – | 37.6% |
| Net margin | – | 101.5% |
| Return on equity | – | – |
| Analyst target vs. price | +41.2% | +20.9% |
| Analyst buy share | 60% | 100% |
| RSI (14) | 50 | 40 |
| 30-day volatility | 30.2% | 22.0% |
| Max drawdown, 1 year | -54.4% | -21.8% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
